The Experts below are selected from a list of 264 Experts worldwide ranked by ideXlab platform
William C. Mcgarity - One of the best experts on this subject based on the ideXlab platform.
-
Value of technetium 99m sestamibi Iodine 123 imaging in reoperative parathyroid surgery.
Surgery, 1993Co-Authors: Collin J. Weber, John H. Vansant, Naomi P. Alazraki, James H. Christy, Nelson B. Watts, Lawrence S. Phillips, Kamal Mansour, Whitaker Sewell, William C. McgarityAbstract:Background. The purpose of this study was to assess the contribution of technetium 99m sestambi Iodine 123 (T/S) imaging to preoperative and intraoperative of patients with persistent hyperparathyroidism. Method. During a period of 10 months, all patients being prepared for reoperative parathyroid surgery (n=10), two patients deemed significant operative risks (one patient with severe chronic obstructive pulmonary disease and one patient with severe cervical spine ankylosing spondylitis), and two patients who had undergone prior thyroid operation were studied were studied with T/S imaging
Kazuo Mizoi - One of the best experts on this subject based on the ideXlab platform.
-
Medulloblastoma with extensive nodularity: single photon emission CT study with Iodine-123 metaiodobenzylguanidine.
AJNR. American journal of neuroradiology, 2002Co-Authors: Yuichiro Naitoh, Toshio Sasajima, Hiroyuki Kinouchi, Shigeki Mikawa, Kazuo MizoiAbstract:We present the case of an infant with medulloblastoma with extensive nodularity, which had been called cerebellar neuroblastoma. MR imaging clearly revealed a nodular enhancement, which appeared as a grape-like lesion. Single photon emission CT revealed markedly high Iodine-123 metaiodobenzylguanidine uptake in the enhancing tumor. Iodine-123 metaiodobenzylguanidine single photon emission CT may be useful in the diagnosis of medulloblastoma with extensive nodularity, which has been considered to be a subgroup of medulloblastoma with extensive neuronal differentiation.
Shunsuke Tamaki - One of the best experts on this subject based on the ideXlab platform.
-
abstract 13677 usefulness of 2 year Iodine 123 metaiodobenzylguanidine based risk model for the post discharge risk stratification in acute decompensated heart failure patients with preserved left ventricular ejection fraction
Circulation, 2020Co-Authors: Shunsuke Tamaki, Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Tetsuya Watanabe, Masatake Fukunami, Yoshio Yasumura, Akito Nakagawa, Yusuke Nakagawa, Masamichi YanoAbstract:Background: A four-parameter risk model including cardiac Iodine-123 metaiodobenzylguanidine (MIBG) imaging and readily available clinical parameters has been recently developed for the prediction ...
-
Abstract 17860: Cardiac Iodine-123 Metaiodobenzylguanidine Imaging Predicts Poor Prognosis Even in Patients Admitted With Acute Decompensated Heart Failure
Circulation, 2015Co-Authors: Shunsuke Tamaki, Takahisa Yamada, Takashi Morita, Yoshio Furukawa, Yusuke Iwasaki, Masato Kawasaki, Atsushi Kikuchi, Takumi Kondo, Masashi Ishimi, Hideyuki HakuiAbstract:Introduction: Cardiac Iodine-123 metaiodobenzylguanidine (MIBG) imaging has been shown to provide prognostic information in patients with chronic heart failure. However, little is known about the p...
-
usefulness of cardiac Iodine 123 meta iodobenzylguanidine imaging to improve prognostic power of seattle heart failure model in patients with chronic heart failure
American Journal of Cardiology, 2011Co-Authors: Yuki Kuramoto, Shunsuke Tamaki, Takashi Morita, Yoshio Furukawa, Yusuke Iwasaki, T Yamada, Yuji Okuyama, Koji Tanaka, Taku Yasui, Hiromichi UedaAbstract:The Seattle Heart Failure Model (SHFM) is a validated prediction model that estimates the mortality in patients with chronic heart failure (CHF) using commonly obtained information, including clinical data, laboratory test results, medication use, and device implantation. In addition, cardiac Iodine-123 meta-iodobenzylguanidine (MIBG) imaging provides prognostic information for patients with CHF. However, the long-term predictive value of combining the SHFM and cardiac MIBG imaging in patients with CHF has not been elucidated. To prospectively investigate whether cardiac Iodine-123 MIBG imaging provides additional prognostic value to the SHFM in patients with CHF, we studied 106 outpatients with CHF who had radionuclide left ventricular ejection fraction 27%) had a significantly greater risk of cardiac death than did those with a normal WR for both those with a SHFM score of ≥ 1 (relative risk 3.3, 95% confidence interval 1.2 to 9.7, p = 0.01) and a SHFM score of ≤ 0 (relative risk 3.4, 95% confidence interval 1.2 to 9.6, p = 0.004). In conclusion, the cardiac MIBG WR provided additional prognostic information to the SHFM score for patients with CHF.
Finn Jensen - One of the best experts on this subject based on the ideXlab platform.
-
Detection of rhinorrhoea by cisternography in combination with single photon emission tomography, following lumbar injection of Iodine-123-labelled albumin
European journal of nuclear medicine, 1992Co-Authors: Jørn Theil Nielsen, Klaus Andersen, Bente V. Nielsen, Jørgen Margversen, Finn JensenAbstract:Eight patients were examined. Seven had verified rhinorrhoea and six had had one or more episodes of pneumococcal meningitis. In four of the patients a fistula could not be visualized by computed tomography. All eight patients had injections of Iodine-123-labelled albumin by lumbar puncture. Tomoscintigraphy (SPET) was performed 3, 6 and 8–9 h after injection. After 6–8 h we were able to demonstrate a fistula in seven of the patients with verified rhinorrhoea and the findings were confirmed by a subsequent operation. In one of the patients we were not able to visualize any leak of cerebrospinal fluid into the nasal cavity. This patient was not operated upon and we were not able to verify the findings in this patient. The operated patients all did well after the operation with no relapse of meningitis. In conclusion, SPECT-cisternography after intralumbar injection of Iodine-123-labelled albumin is a valuable diagnostic tool for the detection of small fistulae in patients with rhinorrhoea.
Wayne C Levy - One of the best experts on this subject based on the ideXlab platform.
-
selective improvement in seattle heart failure model risk stratification using Iodine 123 meta iodobenzylguanidine imaging
Journal of Nuclear Cardiology, 2012Co-Authors: Eric S Ketchum, Arnold F Jacobson, James H Caldwell, Manuel D Cerqueira, Gregory S Thomas, Denis Agostini, Jagat Narula, Wayne C LevyAbstract:Background The Seattle Heart Failure Model (SHFM) is a multivariable model that uses demographic and clinical markers to predict survival in patients with heart failure. Inappropriate activation of the sympathetic nervous system, which contributes to the progression of heart failure and increased mortality, can be assessed using Iodine-123 meta-iodobenzylguanidine (MIBG) cardiac imaging. This study investigated the incremental value of MIBG cardiac imaging when added to the SHFM for prediction of all-cause mortality.
